For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Omnicell, Inc (NASDAQ: OMCL) closed at $31.0 in the last session, down -1.96% from day before closing price of $31.62. In other words, the price has decreased by -$1.96 from its previous closing price. On the day, 0.57 million shares were traded. OMCL stock price reached its highest trading level at $32.05 during the session, while it also had its lowest trading level at $30.94.
Ratios:
We take a closer look at OMCL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.16.
On October 31, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $44 to $57. Barclays Upgraded its Underweight to Equal Weight on August 02, 2024, whereas the target price for the stock was revised from $26 to $39.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 12 ’25 when Manley Corey J sold 3,880 shares for $33.25 per share. The transaction valued at 129,010 led to the insider holds 110,653 shares of the business.
Manley Corey J bought 3,880 shares of OMCL for $129,010 on Sep 12 ’25. On Mar 14 ’25, another insider, LIPPS RANDALL A, who serves as the CHAIRMAN, PRESIDENT AND CEO of the company, bought 10,561 shares for $33.13 each. As a result, the insider paid 349,874 and bolstered with 333,610 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OMCL now has a Market Capitalization of 1423961856 and an Enterprise Value of 1409367808. As of this moment, Omnicell,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 62.84, and their Forward P/E ratio for the next fiscal year is 18.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 11.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.24 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 1.226 whereas that against EBITDA is 19.026.
Stock Price History:
The Beta on a monthly basis for OMCL is 0.88, which has changed by -0.27144533 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, OMCL has reached a high of $55.74, while it has fallen to a 52-week low of $22.66. The 50-Day Moving Average of the stock is -0.00%, while the 200-Day Moving Average is calculated to be -10.23%.
Shares Statistics:
According to the various share statistics, OMCL traded on average about 537.78K shares per day over the past 3-months and 622160 shares per day over the past 10 days. A total of 46.42M shares are outstanding, with a floating share count of 44.42M. Insiders hold about 3.31% of the company’s shares, while institutions hold 104.33% stake in the company. Shares short for OMCL as of 1756425600 were 1936872 with a Short Ratio of 3.60, compared to 1753920000 on 2041890. Therefore, it implies a Short% of Shares Outstanding of 1936872 and a Short% of Float of 6.0900003.
Earnings Estimates
At present, 8.0 analysts are actively evaluating the performance of Omnicell, Inc (OMCL) in the stock market.The consensus estimate for the next quarter is $0.48, with high estimates of $0.54 and low estimates of $0.43.
Analysts are recommending an EPS of between $1.66 and $1.47 for the fiscal current year, implying an average EPS of $1.55. EPS for the following year is $1.69, with 8.0 analysts recommending between $1.84 and $1.3.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $295.59M. It ranges from a high estimate of $298.12M to a low estimate of $294.06M. As of the current estimate, Omnicell, Inc’s year-ago sales were $282.42MFor the next quarter, 8 analysts are estimating revenue of $295.32M. There is a high estimate of $302.42M for the next quarter, whereas the lowest estimate is $283.7M.
A total of 8 analysts have provided revenue estimates for OMCL’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.14B, resulting in an average revenue estimate of $1.15B. In the same quarter a year ago, actual revenue was $1.11BBased on 8 analysts’ estimates, the company’s revenue will be $1.19B in the next fiscal year. The high estimate is $1.22B and the low estimate is $1.16B.
